🛡️

Immunotherapy

Treatments that harness the immune system to fight disease, including checkpoint inhibitors, CAR-T therapies, and cancer vaccines.

Companies

Pipeline Drugs

Key People

Immunotherapy Pipeline (8 drugs)

Commercial: 3Phase 2: 1Phase 1/2: 1Pre-clinical: 1Development/Validation: 1Phase 1/III: 1

Drug	Company	Indication	Phase	Status
CY-101	Cytovation	Adrenocortical Carcinoma	Phase 2	Initiate 2H-25
CY-101 + Pembrolizumab	Cytovation	Colorectal Cancer	Phase 1/2	Initiate 1H-26
SADC Platform	Ablevia	Multiple (Anti-Drug Antibodies, Gene Therapy Neutralizing Antibodies, Autoimmune Conditions)	Pre-clinical	Active
TxPredictor for Transplant Medicine	Pirche	Donor-Recipient Matching & Immune Risk Assessment (Solid-organ & Bone Marrow)	Commercial	Active
TxPredictor for Cell Therapy	Pirche	Donor Selection for Allogeneic Cell Therapies	Development/Validation	Active
Padeliporfin VTP	ImPact Biotech	Upper Tract Urothelial Carcinoma (UTUC)	Phase 1/III	Active
PROphet	OncoHost	Broad Oncology (PD‑1/PD‑L1 inhibitor candidates)	Commercial	Active
PROphetNSCLC	OncoHost	Non‑Small‑Cell Lung Cancer	Commercial	Active